Alteplase injection
Ended Awarded
- Contract number
- SPE2DX25FTQQB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $22,448
Award facts
- Contract value 100% obligated
- $22,447.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA), operating under the Medical Supply Chain division of the Department of Defense, awarded a delivery order valued at $22,447.91 to DMS Pharmaceutical Group Inc. for the supply of Alteplase Injection. This firm fixed-price delivery order, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a standalone purchase from DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. The contract carries no set-aside designation, allowing the vendor to compete on equal footing despite its status as a woman-owned small business. The pharmaceutical product will be delivered to Park Ridge, Illinois, supporting the medical supply needs of Department of Defense healthcare facilities.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as the prime contractor. The company maintains a significant single-award IDC with the DLA valued at $499,999,999 through November 2026, which authorizes the issuance of delivery orders for comprehensive pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables. This particular delivery order for Alteplase Injection—a thrombolytic medication used in acute medical settings—exemplifies the ongoing pharmaceutical supply operations supporting military healthcare operations. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, providing direct distribution services to Department of Defense healthcare sites nationwide.
Quick answers
Who was awarded contract SPE2DX25FTQQB?
SPE2DX25FTQQB was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 10, 2025.
How much is contract SPE2DX25FTQQB worth?
The government has obligated $22,448 on SPE2DX25FTQQB.
Is contract SPE2DX25FTQQB an order under another contract?
Yes. SPE2DX25FTQQB is a delivery order under SPE2DX15D9901, an indefinite delivery contract.
Was contract SPE2DX25FTQQB competed?
The extent of competition for SPE2DX25FTQQB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award